[Edaily Reporter Park Sun-Yeop ] SAMG Entertainment’s (SAMG ENTERTAINMENT CO.,LTD(419530)) flagship intellectual property (IP), the “Catch! Tinipping” series, will be released on Disney+ Korea. SAMG ENTERTAINMENT CO.,LTD announced on the 16th that it will sequentially release all seasons of the “Catch! Tinipping” TV series on Disney+ over a six-week period starting with Season 6, “Princess Catch! Tinipping,” on the 17th and continuing through the 21st of next month. (Photo courtesy of SAMG ENTERTAINMENT CO.,LTD) Season 5, “Shooting Star Catch! Tinipping,” will be released on the 24th, and Season 4, “Sweet and Sour Catch! Tinipping,” on the 31st. Season 3, “Mysterious Catch! Tinipping,” will be available on the 7th of next month, followed by Season 2, “Sparkling Catch! Tinipping,” on the 14th, and Season 1, “Catch! Tinipping,” on the 21st. The movie “Love Hachuping” will also be available on Disney+ starting on the 24th. As the first installment of the “Catch! Tinipping” theatrical trilogy, “Love Hachuping” was released in 2024 and set a new box office record for Korean animation, attracting a cumulative audience of 1.24 million. The sequel, “Love Hachuping: The Legend of the Whale Gem,” is scheduled to be released on the 5th of next month. “Catch! Tinipping” is SAMG ENTERTAINMENT CO.,LTD’s flagship content, which has maintained its popularity since its premiere in 2020 by introducing new stories and characters each season. The company has expanded its business scope beyond the TV series to include movies, live performances, toys, licensing, and brand stores. A SAMG ENTERTAINMENT CO.,LTD representative stated, “We are pleased to present ‘Catch! Tinipping’ through the global streaming service Disney+,” adding, “We hope this collaboration will serve as a stepping stone toward various IP partnerships.”
The way global private equity fund (PEF) managers invest in rental housing is evolving. Previously, most cases involved directly purchasing individual properties. However, transactions have recently e…
SK hynix has drawn a clear line regarding reports that it is pursuing the sale of its stake in its Chongqing, China, plant, stating, “Nothing has been finalized.” This is the company’s response to a r…
Medy-Tox Inc.(086900)Medytox continued its revenue growth in the second quarter of this year, driven by expanded overseas sales of botulinum toxin and dermal fillers, as well as the successful market …